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ABSTRACT
Aims: The occurrence of vaginal pathogens associated with genital tract infections [GTIs]
was investigated in this study.
Study Design: Over a three-month period, 106 High Vaginal Swab [HVS] samples were
obtained from women with genital tract infections [GTIs] within the ages of 15 – 50 years
attending In- and Out- patients clinic at General Hospital, Ijebu-Ode, Ogun State, Nigeria
and percentage frequencies of isolates were determined comparatively.
Place and Duration of Study: Collections of samples were made at General Hospital,
Ijebu-Ode, Ogun State while microbiological analyses on samples were carried out at the
Department of Microbiology and Parasitology, Olabisi Onabanjo University Teaching
Hospital [OOUTH], Sagamu, Ogun State, between August and November, 2011.
Methodology: Samples were screened for the presence of vaginal pathogens using
conventional microbiological techniques. Potato dextrose agar [PDA] was employed to
isolate and enumerate Candida species. Chocolate agar was used for the isolation of
Neisseria gonorrheae, while Columbia agar base in 10% CO2-enriched atmosphere was
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employed for the isolation of Gardnerella vaginalis. Microscopic examinations of smears
were carried out to determine the presence of Trichomonas vaginalis. Paired sample t-test
was employed to analyze results statistically.
Results: Candida species recorded the highest prevalence of 58 [54.7%], followed by
Trichomonas vaginalis 27 [25.5%], Gardneralla vaginalis 12 [11.3%], while Neisseria
gonorrhea recorded the least prevalence of 09 [8.5%]. Among the Candida isolates
obtained, Candida albicans had the highest prevalence of 39 [67.2%], followed by 11 [19%]
Candida tropicalis, 6 [10.3%] Candida parapsilosis while the least occurred was Candida
krusei with 2 [3.5%]. Results also showed that the incidence of Candida species was
highest within the age group of between 21 and 30 years except Candida tropicalis which
recorded highest incidence within the age range of 15 – 20 years. Statistical analyses
established that there was no significant difference between the incidence of Candida sp
and other vaginal pathogens.
Conclusion: Vaginal pathogens are directly associated with genital tract infections and this
is on the high side among women in the developing world like Nigeria. This calls for
commitment to routine evaluation and appropriate intervention in antenatal clinics.
Keywords: Vagina; Candida; pathogens; women; prevalence; GTIs.
1. INTRODUCTION AND LITERATURE REVIEW
The genus Candida and species C. albicans was described by a botanist - Christine Marie
Berkhout - in her doctoral thesis at the University of Utrecht in 1923 as reported by Bodey [1].
Over the years, the classification of the genera and species has evolved. Obsolete names for
this genus include Mycotorula and Torulopsis. The species have also been known in the past
as Monilia albicans and Odium albicans. The current classification is nomen conservandum,
which means the name is authorized for use by the International Botanical Congress [IBC]
[2]. The genus Candida includes about 150 different species. However, only a few are known
to cause human infections. C. albicans is the most significant pathogenic species [3,2]. Other
Candida species pathogenic to humans include C. tropicalis, C. glabrata, C. krusei, C.
parapsilosis, C. dubliniensis and C. lusitaniae [2]. Candida species are frequently part of the
human bodies’ normal oral and intestinal flora. The yeast is a common commensal of the
gastrointestinal tract. Most Candida infections are opportunistic occurring in debilitated
persons [2].
The clinical diagnosis of vaginal candidiasis is unreliable [4,5,6,7], and laboratory
confirmation is needed. More recently, however, it has been shown that symptomatic
candidiasis is usually associated with higher numbers of vaginal yeasts than those found in
asymptomatic carriers [6,8,9]. Unfortunately, conventional mycological laboratory techniques
for yeast quantification involve serial dilutions [8], and dip slides or broth media do not allow
for quantification [10,11,12].
Candidiasis has been associated with prolonged broad spectrum antibiotic therapy. Many
different clinical forms of candidiasis are known, involving primarily the mucosal surfaces
[thrush], gastrointestinal or urogenital tract, and deep-seated infections such as candidemia
or meningitis. Candida vaginitis is a common infection during pregnancy [13]. Infection of the
vagina or vulva may cause severe itching, burning, soreness, irritation, and whitish or
whitish-gray cottage cheese-like discharges, often with a curd–like appearance. These
symptoms are also present in the more common bacterial vaginosis [14,15,16].
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However, some other groups of microorganisms have also been indicted as being involved in
vaginal infections. Gardnerella vaginalis is a facultative anaerobic Gram-variable rod that can
cause bacterial vaginosis in some women as a result of a disruption in the normal vaginal
microflora. The resident anaerobic Lactobacilli population in the vagina is responsible for the
acidic environment. Once the anaerobes have supplanted the normal vaginal bacteria,
prescription antibiotics with anaerobic coverage may have to be given to eliminate the G.
vaginalis and allow the balance to be restored [17,15,16]. While typically isolated in genital
cultures, it may also be detected in other samples from blood, urine, and pharynx. G.
vaginalis is sexually transmitted. Although G. vaginalis is a major species present in bacterial
vaginosis, it can also be isolated from women without any signs or symptoms of infection.
Symptoms include vaginal discharge, vaginal irritation, and a "fish like" odor. In the "amine
whiff test" 10% KOH is added to the discharge, a positive result indicated if a fishy smell is
produced. These and other tests can be used to distinguish between vaginal symptoms
related to G. vaginalis from those caused by other organisms, such as Trichomonas and
Candida albicans, which require different treatment [18]. A selective medium for G. vaginalis
is colistin-oxolinic acid blood agar [18].
Gonorrhoea is a common sexually transmitted infection caused by the bacterium - Neisseria
gonorrheae [also called Gonococcus, which is often abbreviated as "GC" by clinicians]. In
both men and women, if gonorrhea is left untreated, it may spread throughout the body,
affecting joints and even heart valves. The infection is transmitted from one person to
another through vaginal, oral, or anal sexual relations; transmission occurs rarely with safe
sex practices of condom usage with lubricants. The incubation period is 2 to 30 days with
most symptoms occurring between 4–6 days after being infected. A small number of people
may be asymptomatic for a lifetime. Between 30% and 60% of people with gonorrhea are
asymptomatic or have subclinical disease [19].
Trichomonas vaginalis [TV] is a protozoan that causes Trichomoniasis. It is a common cause
of vaginitis in women and occasionally, urethritis in men. The condition is localized and
considered to be sexually transmitted in the majority of patients. The parasite T. vaginalis
can survive outside the body in a moist environment; extracorporeal transmission by fomite is
a theoretical possibility. A proportion of women, especially in the older age group, are
asymptomatic carriers; in others, the vaginitis ranges from mild to severe. In men,
Trichomonas vaginalis is not commonly recognized. This may be due to the infection being
mild or asymptomatic or because the parasite is not regularly looked for even in the presence
of urethritis. And it is also possible that T. vaginalis is commonly inhibited from colonizing the
male urethra for any length of time [20]. In infected female patients, symptoms include:
vaginal discharge, vulvar pruritis, dysuria and dyspareunia. Classical green, frothy, foul-
smelling discharge occurs in 10% of the women, and the red granular ‘strawberry’ cervix can
be identified by the naked eye in less than 2% of patients [21,22]. However, up to 50% of the
infected female patients are asymptomatic, depending on the study population, selection
criteria and diagnostic methods used.
There is lack of simple, cheap and reliable diagnostic tools for the evaluation and
management of GTIs. Available clinical approaches have low sensitivity and/or specificity
and do not appear to serve in all settings. Genital tract infections affect pregnancy outcome
adversely. The effective controls of GTIs have both individual and public health relevance.
Interventions that have been proven to affect disease rates include effective treatment with
appropriate antibiotics and efficient case-finding through improved diagnosis. Therefore, the
aim of this study is to determine the prevalence of vaginal pathogens with special reference
to Candida species
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2. MATERIALS AND METHODS
2.1 Sampling
A total number of 106 patients with genital tract infections attending in- and out- patients’
clinic of General Hospital, Ijebu-Ode, Ogun State, Nigeria were investigated.
2.2 Collection of High Vaginal Swabs [HVS]
A high vaginal swab was collected using sterile swabs. The sterile swabs were obtained
ready for use. Gloves were worn and broken skin or wounds were covered with Elastoplast
during the handling of urogenital specimens to prevent contamination. High vaginal swabs
were collected using a vagina speculum. The cervix was first examined, including the vaginal
walls, and colour, consistency, and the source of the discharge were noted. Two test tubes
were used, marking one tube “HVS.”, and leaving the other tube unmarked. The speculum
was inserted into the fully opened vagina, and a bright lamp was used to examine the cervix
and the vaginal walls. In the collection of HVS specimens, the sterile swab from the tube
marked “HVS” was taken and passed high into the posterior fornix of the vagina [the highest
part of the vagina] and rolled for a few seconds to collect the secretions. The swab was
returned into the test-tube. The specimens were then taking into the laboratory without delay
for processing and examination.
2.3 Examination of Specimen
2.3.1 Microscopic examination
Each sterile swab was labeled with patients’ laboratory number using a grease pencil. Glass
slides were cleaned using gauze and were also labeled with the patients’ laboratory number.
A drop of physiological saline was dropped and smeared on the slide. This was properly
mixed using the swab stick and covered with a cover-slip. The slide was examined under the
microscope using the oil immersion lens, x10 objective lens and x 40 objective lens for a
more detailed structure.
2.3.2 Culturing method
Each swab was streaked on the appropriate culture medium. Potato dextrose agar [PDA]
[Oxoid] was employed to isolate and enumerate Candida species. Growth on PDA was
identified by cultural characteristics, morphotyping, microscopy and battery of biochemical
tests. On PDA, cream-coloured pasty colonies with characteristic yeast smell whose Grams
reaction appears large [3-6m by 6-10m] positive cocci were subsequently confirmed to be
yeast cells [23]. Any multiple colonies were separately identified. This was incubated for 3 –
5 days at 37ºC to allow development of yeast colonies. Chocolate agar [Oxoid] was used for
isolation of Neisseria gonorrhoeae and sub-culturing was made on modified Thayer-Martin
plate warmed to room temperature using a sterile loop. Cultures were incubated for 18 - 24
hours at 35 - 37ºC in the candle jar and plates examined for the presence of typical growth.
Cultures showing no growth or atypical growth were re-incubated and examined again after
an additional 24 hours.  Plates with typical growth were evaluated by testing for the
production of oxidase. Oxidase positive cultures were smeared, stained and examined
microscopically. Columbia agar base was employed for isolation of Gardnerella vaginalis in
10% CO2-enriched atmosphere with incubation temperature of 37ºC for 1 - 2 days. The
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morphological characteristics of colonies allowed initial diagnosis of the organisms causing
disease symptoms [13].
2.4 IDENTIFICATION OF VAGINAL PATHOGENS
2.4.1 Cultivation on the selective medium [Chrom agar]
Chrom agar is selective medium, which indicates an increase in the number of non-albicans
species based on a colour change. It can be used for identification of individual non-albicans
species, as well as C. albicans, if germ tube test was not characteristic. All pure cultures of
yeasts from PDA was cultivated on a Chrom agar. This was incubated at 37ºC for 48 hrs and
identification of yeast was performed based on a colony colour. Using this method, individual
non-albicans species: C. tropicalis [blue colonies, wet], C. krusei [light pink colonies, dry], C.
parapsilopsis [cream colonies, wet] and C. albicans [green colonies, wet] were identified.
2.4.2 Yeast assimilation test [API test]
This test represents the safest identification of non-albicans species. Test is based on the
ability of yeast to assimilate coal hidra [organic compounds]. Premade factory tests of high
sensitivity and precision [API YZC AUX] was used. This test was performed with the ‘pure
cultures’ obtained on PDA. Due to the reliability of this method, we tested all non-albicans
species using this test, confirming the results obtained by cultivation on Chrom agar.
Assimilation test, germ tube test and pseudohyphae tests were all carried out for the
identification of Candida species according to the methods described by Ochei and Kolhatkar
[24]. Sugar assimilation procedures were conducted using minimal sugar-free nitrogen-
containing basic agar, inoculated with highly turbid suspension of overnight subculture of
each yeast-like cells. The preparation was allowed to set, dried and previously sugar-
impregnated-discs were placed on the plates and incubated overnight. A milky halo formation
around each disc corresponds to diffusion zone of that particular sugar and hence its
assimilation. Where necessary, organisms were also checked for urease production, nitrate
assimilation, and ascospore formation [25]. Other tests carried out for the identification
vaginal isolates include sugar fermentation test, capsule staining with Indian ink, Gram’s
staining and other biochemical tests in accordance with the descriptions of Cheesebrough
[26] and Ochei and Kolhatkar [24].
2.5 Statistical Analysis
Paired sample t-test was performed to analyze results statistically using the SPSS version
15.
3. RESULTS AND DISCUSSION
In this study, 106 females with age ranging from 15 – 50 years, who had been diagnosed
clinically for the presence of one or more vaginal pathogens were recruited to participate.
Tables 3.1a and 3.1b showed the biochemical characterization of Candida species and 2
bacterial genera, respectively. The morphological characteristics of Trichomonas vaginalis
was shown in Table 3.1c. The identified Candida include C. albicans, C. krusei, C. tropicalis
and C. parapsilopsis [Table 3.1a]
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Table 3.2 showed the distribution of vaginal pathogens obtained among selected age range
of 15 and 50 years. The highest prevalence of vaginal pathogens was recorded within the
age range of 21 – 30 years. It was, however, amazing that the age range of 15 – 20 years
recorded the second highest prevalence rate of vaginal pathogens despite the smallest class
size out of four groups. Gardnerella vaginalis had the lowest occurrence in the age range of
between 31 – 40 years. However, in all, Candida species recorded the highest incidence of
54.7% while Neisseria gonorrheae recorded the lowest prevalence of 8.5% [Table 3.2].
This study also put into cognizance the distribution of the vaginal pathogens among In-
patients and Out-patients. Out of the total of 106 patients screened, 74 were out patients
while 32 were in patients. It was, however recorded that the incidence of the vaginal
pathogens was higher among the out-patients, except the bacterium - Gardnerella vaginalis
– whose incidence was higher among the in-patients. It can also be pointed out that the
incidence of Neisseria gonorrheae was lowest among the in-patients [3.13%]; and among the
out-patients, Gardnerella vaginalis and Neisseria gonorrheae possessed lowest percentage
frequency of 10.8% [Table 3.3].
Studies were further conducted to determine the distribution of Candida species within the
age range of 15 – 50 years.  It was discovered that out of the 58 Candida species, 39
[67.2%] were Candida albicans, followed by 11[19%] Candida tropicalis, 6[10.3%] Candida
parapsilosis and 2[3.5%] Candida krusei.  It was, however, noticeable that the occurrence of
Candida species was highest within the age group of between 21 and 30 years except
Candida tropicalis which recorded highest within the age group of 15 – 20 [Table 3.4]. This
information gives an insight on the distribution of Candida species that are associated with
genital tract infections aside the popularly indicted C. albicans.
It was statistically established that there was no significant difference between the paired
observations performed on Candida sp Vs. Gardnerella vaginalis, Candida sp Vs.
Trichomonas vaginalis, Candida sp Vs. Neisseria gonorrhea and Gardnerella vaginalis Vs.
Neisseria gonrrrhea. In the contrary, however, the mean difference in the incidence of
Gardnerella vaginalis Vs. Trichomonas vaginalis was significant [P < 0.05] [Table 3.5].
Comparative studies of genital tract colonization [asymptomatic] by Candida species with
microbiological evidence are difficult. Many studies examine tertiary hospital populations and
may include or target only those with symptoms of vaginitis. Worldwide estimates of genital
Candida colonization range from 17% in Turkey to up to 30% in a U.S. study of
asymptomatic young women followed over 12 months [27-33]. These estimates, reported by
the authors, were less compared with 54.7% incidence rate obtained in this study [Table 3.3].
These results also showed higher incidence rate of C. albicans [40%] [Table 3.3] compared
with a study of 1009 women in New Zealand where C. albicans was isolated from vagina of
19% of apparently healthy women [34]. The proportion of genital infections by C. albicans in
symptomatic women ranged from approximately 65% in Belgium [30], Turkey [31], and Saudi
Arabia [35] to approximately 90% in U.S. and Australian samples [28,32].
Candida yeasts are commonly present in humans, and their growth is normally limited by the
human immune system and by other microorganisms, such as bacteria occupying the same
locations [niches] in the human body [36]. Douches or internal disturbances [hormonal or
physiological] can perturb the normal vaginal flora such as lactobacilli and result in an
overgrowth of Candida cells causing symptoms of infection, such as local inflammation.
Pregnancy and uses of oral contraceptives have been reported as a risk factor [37], while the
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roles of engaging in vaginal sex immediately and without cleansing after anal sex and using
lubricants containing glycerin remain controversial.
In conclusion, this study showed that incidence rate of GTIs among women in the developing
Countries like Nigeria is on the high side and calls for commitment to routine evaluation and
appropriate intervention in antenatal clinics. The changes in sexual behavior can be inferred
from changing incidence rates in Western countries. The greatest gains are achieved when
all elements are included in an integrated strategy. However, the complexity of the
interrelationship of these disparate factors means that a lower rate of disease attained by
one means may be offsetted by a decline in compliance in another effector arm. For
example, improved case-finding through better diagnostic tests and instigation of proper
treatment regimens may provide gains which are offset by deleterious behavioral change,
and vice versa.
Table 3.2 showed the distribution of vaginal pathogens obtained among selected age range
of between 15 and 50 years. Candida species recorded the highest prevalence of [54.7 %]
while Neisseria gonorrheae recorded the least prevalence of [8.5%].
Table 3.3 showed the distribution of vaginal pathogens in In- patients and Out-patients
examined in this study. It was recorded that the incidence of the vaginal pathogens was
higher among the out-patients, except the bacterium - Gardnerella vaginalis – whose
incidence was higher among the in-patients.
Table 3.4 showed the distribution of Candida species within the age range of 15 – 50 years.
Candida albicans recorded the highest incidence of 67.2 % in all cases while C. krusei
recorded the least prevalence of 3.5%. Occurrence of Candida species was highest within
the age group of between 21 and 30 years except Candida tropicalis which recorded highest
within the age group of 15 – 20.
The calculated P-value is greater than 0.05 in paired comparison tests performed on
Candida sp Vs. Gardnerella vaginalis, Candida sp Vs. Trichomonas vaginalis, Candida sp
Vs. Neisseria gonorrhea and Gardnerella vaginalis Vs. Neisseria gonrrrhea indicating that
the mean differences between the paired observations were not significantly different.
However, the mean difference between Gardnerella vaginalis Vs. Trichomonas vaginalis
was significant [P < 0.05] [Table 3.5].
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Table 3.1a. Biochemical reactions of Candida isolates





































































39 + + + - - AG AG AG - - + + - C. albicans
2 + - - - - AG - - - - + - - C. krusei
11 + + + - - AG AG AG - - + - - C. tropicalis
6 + + + - - AG - - - - + - - C.
parapsilopsis
Keys:           AG = Acid and Gas;                     + = Positive; - = Negative
Species of Candida identified include C. albicans, C. krusei, C. tropicalis and C. parapsilopsis



























































































































Keys: +   = present/positive; - = absent/negative
Two bacterial isolates were obtained in this study and these include Nesseria gonorrheae and Gardnerella vaginalis.
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Key: + = present/positive
Twenty-seven [27] isolates were identified by their shapes, flagella with undulating membrane,
axostyle, and jerky/rapid motility as Trichomonas vaginalis.
Table 3.2 Distribution of vaginal pathogens among selected age range








15 – 20 32 15 [46.9%] 05 [15.6%] 10 [31.3%] 02 [6.3%]
21 – 30 47 30 [63.8%] 04 [8.5%] 10 [21.3%] 03 [6.4%]
31 – 40 20 08 [40%] 03 [15%] 05 [25%] 04 [20%]
41 – 50 07 05 [71.4%] 0 [0%] 02 [28.6%] 0 [0%]
Total 106 58 [54.7%] 12 [11.3%] 27 [25.5%] 09 [8.5%]
Keys: n [%] = Percentage of Patient infected; N = Number of Patient Tested













In – patients 32 20 [62.5%] 04 [12.5%] 07 [21.9%] 01 [3.13%]
Out – patients 74 38 [51.4%] 08 [10.8%] 20 [27.0%] 08 [10.8%]
Total 106 58 [54.7%] 12 [11.3%] 27 [25.5%] 09 [8.5%]
Keys: n [%] = Percentage of Patient infected;N = Number of Patient Tested
Table 3.4. Distribution of Candida species by age








15 – 20 15 08 [53.3%] 02 [13.3%] 05 [33.3%] 01[6.7%]
21 – 30 30 24 [80%] 02 [6.7%] 04 [13.3%] 0 [0]
31 – 40 08 05 [62.5%] 01 [12.5%] 02 [25%] 0 [0]
41 – 50 05 02 [40%] 01 [20%] 0 [0] 01 [20]
Keys: n [%] = Percentage of Patient infected; N = Number of Patient Tested
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Table 3.5. Determination of the relationships among vaginal pathogens using Paired Samples Test













Lower Upper Lower Upper Lower Upper Lower Upper
Pair 1 Candida sp – Gardnerella
vaginalis
11.500 9.950 4.975 -4.332 27.332 2.312 3 .104
Pair 2 Candida sp –
Trichomonas vaginalis
7.750 8.221 4.110 -5.331 20.831 1.885 3 .156
Pair 3 Candida sp – Neisseria
gonrrrhea
12.000 10.893 5.447 -5.334 29.334 2.203 3 .115
Pair 4 Gardnerella vaginalis –
Trichomonas vaginalis
-3.750 2.062 1.031 -7.030 -.470 -3.638 3 .036
Pair 5 Gardnerella vaginalis –
Neisseria gonrrrhea
.500 2.082 1.041 -2.812 3.812 .480 3 .664
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